Demographic and disease characteristics of patients referred for gold treatment.
| Characteristic | No. (%) |
|---|---|
| Gender, n = 81 | |
| Female | 69 (85) |
| Male | 12 (15) |
| Age, yrs, n = 71 | |
| ≤ 30 | 3 (4) |
| 31–50 | 21 (30) |
| 51–70 | 35 (49) |
| > 70 | 12 (17) |
| Diagnosis, n = 81 | |
| Rheumatoid arthritis | 71 (88) |
| Psoriatic arthritis | 5 (6) |
| Juvenile idiopathic arthritis | 2 (2) |
| Undifferentiated polyarthritis | 1 (1) |
| Sjögren’s syndrome | 1 (1) |
| Spondyloarthritis | 1 (1) |
| Disease duration, yrs, n = 71* | |
| < 2 | 19 (27) |
| 2–5 | 19 (27) |
| 6–10 | 7 (10) |
| 11–20 | 19 (27) |
| > 20 | 7 (10) |
| Rheumatoid factor, n = 81 | |
| Positive | 63 (78) |
| Negative | 13 (16) |
| Unknown | 5 (6) |
↵* Counts and percentages based on available data. Ten patients never started gold and thus disease duration and age at time of admission to clinic were not applicable.